|
Market Closed -
OTC Markets
15:47:56 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | - |
| Market Cap | 716K 629K 593K 542K 1.01M 68.69M 1.02M 7.1M 2.75M 34.99M 2.69M 2.63M 114M | P/E 2024 |
-0.6x | P/E 2025 | -0.38x |
|---|---|---|---|---|---|
| Enterprise Value | 12.04M 10.58M 9.97M 9.11M 17.02M 1.16B 17.17M 119M 46.28M 588M 45.2M 44.21M 1.91B | EV / Sales 2024 |
27.1x | EV / Sales 2025 | 31.2x |
| Free-Float |
98.98% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 month | +9,900.00% | ||
| 3 months | -50.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0 |
| 10 years | 0 | | 0.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Flax
CEO | Chief Executive Officer | 56 | 2001-10-31 |
Joe Lucas
COO | Chief Operating Officer | - | - |
| Chief Tech/Sci/R&D Officer | 64 | 2016-07-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Garry Pottruck
BRD | Director/Board Member | 68 | 2009-07-28 |
Stewart Lonky
BRD | Director/Board Member | 78 | 2004-11-04 |
Michael Flax
BRD | Director/Board Member | 56 | 2001-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/21/26 | Don | Executive/Senior Manager | -12,000,000 | 100.0000% | ||
| 8/21/26 | Other | Executive/Senior Manager | 0 | 0% | ||
| 11/15/21 | Buy | Executive/Senior Manager | 12,000,000 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | 0.00% | +9,900.00% | 716K | |
| -2.90% | -1.91% | -13.91% | -6.12% | 13.65B | |
| -1.14% | +0.78% | -31.71% | -56.47% | 4.82B | |
| -1.95% | -1.85% | -3.61% | -7.06% | 4.38B | |
| -2.07% | -0.26% | -5.02% | -33.83% | 3.85B | |
| -0.73% | +2.99% | -19.98% | +4.65% | 3.52B | |
| -0.65% | -3.78% | -3.44% | -5.46% | 3.37B | |
| -1.51% | -1.65% | -15.50% | +0.81% | 3.09B | |
| -1.09% | -1.29% | -20.31% | -18.56% | 2.27B | |
| -0.87% | +0.88% | -25.66% | -22.54% | 1.65B | |
| Average | -1.29% | -0.50% | -13.91% | +975.54% | 4.06B | |
| Weighted average by Cap. | -1.85% | -0.98% | -14.68% | -14.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 392K 345K 325K 297K 555K 37.62M 559K 3.89M 1.51M 19.17M 1.47M 1.44M 62.28M | 385K 339K 319K 292K 545K 36.97M 549K 3.82M 1.48M 18.83M 1.45M 1.42M 61.19M |
| Net income | -1.29M -1.13M -1.06M -973K -1.82M -123M -1.83M -12.75M -4.94M -62.84M -4.83M -4.72M -204M | -2.05M -1.8M -1.7M -1.55M -2.9M -196M -2.92M -20.3M -7.87M -100M -7.69M -7.52M -325M |
| Net Debt | 9.91M 8.71M 8.2M 7.5M 14.01M 951M 14.13M 98.23M 38.09M 484M 37.2M 36.39M 1.57B | 11.32M 9.95M 9.37M 8.57M 16.01M 1.09B 16.14M 112M 43.53M 553M 42.51M 41.58M 1.8B |
Employees
6
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-23 | US$0.000100 | 0.00% | 321,375 |
| 26-09-22 | US$0.000100 | 0.00% | 55,000 |
| 26-09-21 | US$0.000100 | 0.00% | 150,000 |
| 26-09-17 | US$0.000100 | 0.00% | 1,360,000 |
- Stock Market
- Stocks
- NPHC Stock
Select your edition
All financial news and data tailored to specific country editions
